Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?

被引:331
作者
Chu, KU [1 ]
Turner, RR [1 ]
Hansen, NM [1 ]
Brennan, MB [1 ]
Bilchik, A [1 ]
Giuliano, AE [1 ]
机构
[1] St Johns Hlth Ctr, John Wayne Canc Inst, Joyce Eisenberg Keefer Breast Ctr, Santa Monica, CA 90404 USA
关键词
D O I
10.1097/00000658-199904000-00013
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To determine the likelihood of nonsentinel axillary metastasis in the presence of sentinel node metastasis from a primary breast carcinoma. Summary Background Data Sentinel lymphadenectomy is a highly accurate technique for identifying axillary metastasis from a primary breast carcinoma. Our group has shown that nonsentinel axillary lymph nodes are unlikely to contain tumor cells if the axillary sentinel node is tumor-free, but as yet no study has examined the risk of nonsentinel nodal involvement when the sentinel node contains tumor cells. Methods Between 1991 and 1997, axillary lymphadenectomy was performed in 157 women with a tumor-involved sentinel node. Fifty-three axillae (33.5%) had at least one tumor-involved nonsentinel node. The authors analyzed the incidence of nonsentinel node involvement according to clinical and tumor characteristics. Results Only two variables had a significant impact on the likelihood of nonsentinel node metastasis: the size of the sentinel node metastasis and the size of the primary tumor. The rate of nonsentinel node involvement was 7% when the sentinel node had a micrometastasis (less than or equal to 2 mm), compared with 55% when the sentinel node had a macrometastasis (>2 mm). In addition, the rate of nonsentinel node tumor involvement in; creased with the size of the primary tumor. Conclusions If a primary breast tumor is small and if sentinel node involvement is micrometastatic, then tumor cells are unlikely to be found in other axillary lymph nodes. This suggests that axillary lymph node dissection may not be necessary in patients with sentinel node micrometastases from T1/T2 lesions, or in patients with sentinel node metastases from T1a lesions.
引用
收藏
页码:536 / 541
页数:6
相关论文
共 31 条
[1]  
Barth A, 1997, CANCER-AM CANCER SOC, V79, P1918, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1918::AID-CNCR12>3.0.CO
[2]  
2-Y
[3]  
Cady B, 1997, J SURG ONCOL, V66, P7, DOI 10.1002/(SICI)1096-9098(199709)66:1<7::AID-JSO3>3.0.CO
[4]  
2-8
[5]  
Cady B, 1997, CANCER-AM CANCER SOC, V79, P1856, DOI 10.1002/(SICI)1097-0142(19970515)79:10<1856::AID-CNCR2>3.0.CO
[6]  
2-E
[7]  
Chontos AJ, 1997, J AM COLL SURGEONS, V184, P493
[8]   Prognostic significance of occult lymph node metastases in node-negative breast cancer [J].
Clare, SE ;
Sener, SF ;
Wilkens, W ;
Goldschmidt, R ;
Merkel, D ;
Winchester, DJ .
ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (06) :447-451
[9]  
Dowlatshahi K, 1997, CANCER, V80, P1188, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1188::AID-CNCR2>3.0.CO
[10]  
2-H